Medtech Market Cautious But OptimisticMedtech Market Cautious But Optimistic

The medtech industry has long been considered a recession-resistant segment of the economy. Although it is not recession-immune, it does show signs of optimism, according to Millennium Research Group (MRG).The research firm says that the medtech markets have already felt the impact from the downturn, although not all segments have been equally affected. Aesthetic and elective markets have been hardest hit, with capital-intensive markets, such as diagnostic imaging, also feeling the pinch.

May 30, 2009

1 Min Read
MDDI logo in a gray background | MDDI

Markets that address critical, acute care concerns such as cardiology have suffered little damage from the economic crisis, but are nonetheless showing that nothing is isolated from the recession's effects.Not all indicators are negative, however. The company says its exclusive MRG data from its new Medtech Confidence Index (MCI) suggests that there is some reason for optimism. The MCI looks at the general economic outlook of practitioners in medtech. Many market players, based on preliminary 2009 MCI data, are cautiously feeling more bullish about the medtech industry's short-term prospects. Overall, however, MRG says that general sentiment remains highly negative, and thus the relative optimism should only be interpreted as a slight increase in outlook relative to a dismal fourth quarter in 2008.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like